|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.10 DKK | +0.85% |
|
-2.46% | -11.72% |
| 10:46am | H. Lundbeck Randomizes Last Patient in Late-stage Trial for Amlenetug | MT |
| 09:47am | Lundbeck completes recruitment for Phase 3 MSA study | FW |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 3.87B | 12.96% | 21.42% | 17.65% | 7.07% | 1.08x | ||
| 359B | 0.92% | 1.56% | - | 5.94% | -0.01x | ||
| 223B | 0.7% | 1.25% | - | 4.06% | 1.5x | ||
| 3.93B | 8.83% | 13.9% | 62.88% | 22.61% | 0.91x | ||
| 5.74B | 8.38% | 10.32% | 15.93% | 9.84% | -0.51x | ||
| 37.71B | 1.65% | 3.29% | 6.5% | 2.1% | 0.99x | ||
| 80.08B | 1.21% | 3.83% | 9.19% | 1.82% | 0.69x | ||
| 4.33B | 4.67% | 5.38% | 12.12% | 6.04% | 2.63x | ||
| 24.52B | 1.1% | 1.51% | 6.6% | 3.6% | -3.53x | ||
| 20.8B | 1.65% | 2.39% | 9.98% | 2.57% | -1.07x | ||
| 6.93B | 3.95% | 5.29% | 12.24% | 5.94% | - | ||
| 8.91B | 1.75% | 3.79% | 9.88% | 3.65% | 1.42x | ||
| 16.03B | 1.44% | 1.55% | 8.4% | 3.32% | -2.88x | ||
| 10.14B | 1.31% | 1.25% | 7.8% | 2.77% | -2.61x | ||
| 10.19B | 0.86% | 0.77% | 3.67% | 1.35% | -1.49x | ||
| 1.11B | 8.54% | 12.08% | 26.94% | 10.22% | - | ||
| Average | 50.99B | 3.75% | 5.6% | 14.98% | 5.81% | -0.21x | |
| Weighted average by Cap. | 217B | 2.41% | 3.81% | 25.73% | 6.83% | 0.41x |
- Stock Market
- Equities
- HLUN B Stock
- Sector H. Lundbeck A/S
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















